JPRN-UMIN000014249已完成未知
Efficacy and safety of combination therapy with GLP-1 analog lixisenatide and long-acting insulin glargine in patients with glucose intolerance or diabetes caused by hyposecretion of endogenous insulin who underwent partial pancreatectomy - Efficacy and safety of combination therapy with GLP-1 analog lixisenatide and long-acting insulin glargine in patients with diabetes who underwent partial pancreatectomy
Division of Diabetes, Endocrinology and Metabolism, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 个研究点目标入组 10 人开始时间: 2014年6月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient for whom insulin treatment is necessary (type 1 diabetes, total pancreatectomy)
研究者
相似试验
已完成
不适用
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20
进行中（未招募）
1 期
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15
进行中（未招募）
1 期
An early phase clinical study to investigate the combination of chemotherapy (Gemcitabine) and the study drug Atu027 in patients with advanced or metastatic pancreas cancerEUCTR2012-004429-26-DESilence Therapeutics GmbH
进行中（未招募）
不适用
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60
已完成
不适用
Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)JPRN-UMIN000033961Chiba University60